Abstract
The E5 oncoprotein of the human papillomavirus type 16 (HPV16 E5) cooperates in cervical carcinogenesis and in epithelial transformation deregulating cell growth, survival and differentiation through the modulation of growth factor receptors. Among the epithelial receptor tyrosine kinases, the keratinocyte growth factor receptor/fibroblast growth factor receptor 2b (KGFR/FGFR2b) is a major paracrine mediator of epithelial homeostasis and appears to have an unique and unusual role in epithelial tissues, exerting a tumor-suppressive function in vitro and in vivo. With the aim to better elucidate the molecular events involved in the pathological activity of 16E5, we investigated if the viral protein would be able to affect the KGFR expression, signaling and turnover by interference with its degradative and recycling endocytic pathways. Quantitative reverse transcriptase–PCR and biochemical approaches on human keratinocytes transfected with 16E5-HA showed that E5 protein is able to induce KGFR down-modulation at both transcript and protein levels. Immunofluorescence microscopy in double-transfected cells expressing both E5 and KGFR revealed that the viral protein alters the receptor endocytic trafficking and triggers its endosomal sorting to the indirect juxtanuclear recycling pathway. The shift from lysosomal degradation to recycling at the plasma membrane correlates with a reduced phosphorylation of the fibroblast growth factor receptor substrate-2α tyrosine 196, the major docking site for Grb2-Cbl complexes responsible for receptor ubiquitination and degradation. 5′-Bromo-deoxyuridine incorporation assay demonstrated that expression of 16E5 induces a decrease in the growth response to the receptor ligands as a consequence of KGFR down-modulation, suggesting that 16E5 might have a role on HPV infection in perturbing the KGFR-mediated physiological behavior of confluent keratinocytes committed to differentiation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ashrafi GH, Haghshenas M, Marchetti B, Campo MS . (2006). E5 protein of human papillomavirus 16 downregulates HLA class I and interacts with the heavy chain via its first hydrophobic domain. Int J Cancer 119: 2105–2112.
Ashrafi GH, Haghshenas MR, Marchetti B, O'Brien PM, Campo MS . (2005). E5 protein of human papillomavirus type 16 selectively downregulates surface HLA class I. Int J Cancer 113: 276–283.
Barbaresi S, Cortese MS, Quinn J, Ashrafi GH, Graham SV, Campo S . (2010). Effects of human papillomavirus type 16 E5 deletion mutants on epithelial morphology: functional characterization of each trnsmembrane domain. J Gen Virol 91: 521–530.
Belleudi F, Leone L, Aimati L, De Paola B, Cardinali G, Marchese C et al. (2006). Endocytic pathways and biological effects induced by UVB-dependent or ligand–dependent activation of the keratinocyte growth factor receptor. FASEB J 20: 395–397.
Belleudi F, Leone L, Maggio M, Torrisi MR . (2009). Hrs regulates the endocytic sorting of the fibroblast growth factor receptor 2b. Exp Cell Res 315: 2181–2191.
Belleudi F, Leone L, Nobili V, Raffa S, Francescangeli F, Maggio M et al. (2007). Keratinocyte growth factor receptor ligands target the receptor to different intracellular pathways. Traffic 8: 1854–1872.
Capone A, Visco V, Belleudi F, Marchese C, Cardinali G, Bellocci M et al. (2000). Up-modulation of the expression of functional keratinocyte growth factor receptors induced by high cell density in the human keratinocyte HaCaT cell line. Cell Growth Differ 11: 607–614.
Ceccarelli S, Cardinali G, Aspite N, Picardo M, Marchese C, Torrisi MR et al. (2007). Cortactin involvement in the keratinocyte growth factor and fibroblast growth factor 10 promotion of migration and cortical actin assembly in human keratinocytes. Exp Cell Res 313: 1758–1777.
Chen SL, Lin ST, Tsai TC, Hsiao WC, Tsao YP . (2007). ErbB4 (JM-b/CYT-1)-induced expression and phosphorylation of c-Jun is abrogated by human papillomavirus type 16 E5 protein. Oncogene 26: 42–53.
Conrad M, Bubb VJ, Schlegel R . (1993). The human papillomavirus type 6 and 16 E5 proteins are membrane-associated proteins which associate with the 16-kilodalton pore-forming protein. J Virol 67: 6170–6178.
Crusius K, Auvinen E, Alonso A . (1997). Enhancement of EGF- and PMA-mediated MAP kinase activation in cells expressing the human papillomavirus type 16 E5 protein. Oncogene 15: 1437–1444.
Crusius K, Auvinen E, Steuer B, Gaissert H, Alonso A . (1998). The human papillomavirus type 16 E5 protein modulates ligand-dependent activation of the EGF receptor family in the human epithelial cell line HaCaT. Exp Cell Res 241: 76–83.
Fehrmann F, Laimins LA . (2003). Human paillomaviruses: targeting differentiating epithelialcells for malignant transformation. Oncogene 22: 5201–5207.
Feng S, Wang F, Matsubara A, Kan M, McKeehan WL . (1997). Fibroblast growth factor receptor 2 limits and receptor 1 accelerates tumorigenicity of prostate epithelial cells. Cancer Res 58: 1509–1514.
Fey A, Eichler S, Flavier S, Christen R, Hofle MG, Guzman CA . (2004). Establishment of a real-time PCR-based approach for accurate quantification of bacterial RNA targets in water using Salmonella as a model organism. Appl Envir Microbiol 70: 3618–3623.
Finch PW, Rubin JS, Miki T, Ron D, Aaronson SA . (1989). Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth. Science 245: 752–755.
Gotoh N . (2008). Regulation of growth factor signaling by FRS2 family docking/scaffold adaptor proteins. Cancer Sci 99: 1319–1325.
Grose R, Fantl V, Werner S, Chioni AM, Jarosz M, Rudling R et al. (2007). The role of fibroblast growth factor receptor 2b in skin homeostasis and cancer development. EMBO J 26: 1268–1278.
Hines MD, Allen-Hoffmann BL . (1996). Keratinocyte growth factor inhibits cross-linked envelope formation and nucleosomal fragmentation in cultured human keratinocytes. J Biol Chem 271: 6245–6251.
Hwang ES, Nottoli T, Dimaio D . (1995). The HPV16 E5 protein: expression, detection and stable complex formation with transmembrane proteins in COS cells. Virology 211: 227–233.
Kivi N, Greco D, Auvinen P, Auvinen E . (2008). Genes involved in cell adhesion, cell motility and mitogenic signalling are altered due to HPV 16 E5 protein expression. Oncogene 27: 2532–2541.
Kouhara H, Hadari YR, Spivak-Kroizman T, Schilling J, Bar-Sagi D, Lax I et al. (1997). A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the ras/MAPK signaling pathway. Cell 89: 693–702.
La Rochelle WJ, Dirsch OR, Finch PW, Cheon HG, May M, Marchese C et al. (1995). Specific receptor detection by a functional keratinocyte growth factor immunonoglobulin chimera. J Cell Biol 129: 357–366.
Leptak C, Cajal SRY, Kulke R, Horwitz BH, Riese DJ, Dotto GP et al. (1991). Tumorigenic transformation of murine keratinocytes by the E5 genes of bovine papillomavirus type 1 and human papillomavirus type 16. J Virol 65: 7078–7083.
Lotti LV, Rotolo S, Francescangeli F, Frati L, Torrisi MR, Marchese C . (2007). AKT and MAPK signaling in KGF-treated and UVB-exposed human epidermal cells. J Cell Physiol 212: 633–642.
Marchese C, Chedid M, Disc OR, Csaky KG, Santanelli F, Latini C et al. (1995). Modulation of keratinocyte growth factor and its receptor in reepithelializing human skin. J Exp Med 182: 1369–1376.
Marchese C, Felici A, Visco V, Lucania G, Igarashi M, Picardo M et al. (2001). Fibroblast growth factor 10 induces proliferation and differentiation of human primary cultured keratinocytes. J Invest Dermatol 116: 623–628.
Marchese C, Rubin J, Ron D, Faggioni A, Torrisi MR, Messina A et al. (1990). Human keratinocyte growth factor activity on proliferation and differentiation of human keratinocytes: differentiation response distinguishes KGF from EGF family. J Cell Physiol 144: 326–332.
Maufort JP, Williams SM, Pitot HC, Lambert PF . (2007). Human papillomavirus 16E5 oncogene contributes to two stages of skin carcinogenesis. Cancer Res 67: 6106–6112.
Miki T, Fleming TP, Bottaro DP, Rubin JS, Ron D, Aaronson SA . (1991). Expression DNA cloning of the KGF receptor by creation of a transforming autocrine loop. Science (Washington DC) 251: 72–75.
Moody CA, Laimins LA . (2010). Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer 10: 550–560.
Oelze I, Kartenbeck J, Crusius K, Alonso A . (1995). Human papillomavirus type 16 E5 protein affects cell-cell communication in an epithelial cell line. J Virol 69: 4489–4494.
Pedroza-Saavedra A, Lam EW, Esquivel-Guadarrama F, Gutierrez-Xicotencatl L . (2010). The human papillomavirus type 16 E5 oncoprotein synergizes with EGF-receptor signaling to enhance cell cycle progression and the downregulation of p27Kip1. Virology 400: 44–52.
Petti L, Nilson LA, DiMaio D . (1991). Activation of the platelet-derived growth factor receptor by the bovine papillomavirus E5 transforming protein. EMBO J 10: 845–855.
Pim D, Collins M, Banks L . (1992). Human papillomavirus type 16 E5 gene stimulates the transforming activity of the epidermal growth factor receptor. Oncogene 7: 27–32.
Regan JA, Laimins LA . (2008). Bap31 is a novel target of the human papillomavirus E5 protein. J Virol 82: 10042–10051.
Rodriguez MI, Finbow ME, Alonso A . (2000). Binding of human papillomavirus 16 E5 to the 16-kDa subunit c (proteolipid) of the vacuolar H-ATPase can be dissociated from the E5-mediated epidermal growth factor receptor overactivation. Oncogene 19: 3727–3732.
Straight SW, Herman B, McCance DJ . (1995). The E5 oncoprotein of human papillomavirus type 16 inhibits the acidification of endosomes in human keratinocytes. J Virol 69: 3185–3192.
Straight SW, Hinkle PM, Jewers RJ, McCance DJ . (1993). The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes. J Virol 67: 4521–4532.
Suprynowicz FA, Krawczyk E, Hebert JD, Sawali RS, Simic V, Kamonjoh CM et al. (2010). The human papillomavirus type 16 E5 oncoprotein inhibits epidermal growth factor trafficking independently of endosome acidification. J Virol 84: 10619–10629.
Talbert-Slagle K, DiMaio D . (2008). The bovine papillomavirus E5 protein and the PDGF β receptor: it takes two to tango. Virology 384: 345–351.
Thomsen P, van Deurs B, Norrild B, Kayser L . (2000). The HPV16 E5 oncogene inhibits endocytic trafficking. Oncogene 19: 6023–6032.
Turner N, Grose R . (2010). Fibroblast growth factor signalling: from development to cancer. Nat Rev Cancer 10: 116–129.
Wakana Y, Takai S, Nakajima K, Tani K, Yamamoto A, Watson P et al. (2008). Bap3 is an itinerant protein that moves between the peripheral endoplasmic reticulum (ER) and the jiuxtanuclear compartment related to ER-associated degradation. Mol Biol Cell 19: 1825–1836.
Wong A, Lamothe B, Lee A, Sclessinger J, Lax I . (2002). FRS2 alpha attenuates FGF receptor signaling by Grb2-mediated recruitment of the ubiquitin ligase Cbl. Proc Natl Acad Sci USA 99: 6684–6689.
Zhang B, Li P, Wang E, Brami Z, Dunn KW, Blum SJ et al. (2003). The E5 protein of human papillomavirus type 16 perturbs MHC class II antigen maturation in human foreskin keratinocytes treated with interferon-γ. Virol 310: 100–108.
Zhang B, Spandau DF, Roman A . (2002). E5 protein of human papillomavirus type 16 protects human foreskin keratinocytes from UVB-irradiation-induced apoptosis. J Virol 76: 220–231.
Zhang B, Srirangam A, Potter DA, Roman A . (2005). HPV16 E5 protein disrupts the c-Cbl–EGFR interaction and EGFR ubiquitination in human foreskin keratinocytes. Oncogene 24: 2585–2588.
Zhang Y, Wang H, Toratani S, Sato JD, Kan M, McKeehan WL et al. (2001). Growth inhibition by keratinocyte growth factor receptor of human salivary adenocarcinoma cells through induction of differentiation and apoptosis. Procl Natl Acad Sci USA 98: 11336–11340.
Acknowledgements
This work was partially supported by grants from MIUR and from AIRC—Associazione Italiana per la Ricerca sul Cancro (IG 10272), Italy.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Belleudi, F., Leone, L., Purpura, V. et al. HPV16 E5 affects the KGFR/FGFR2b-mediated epithelial growth through alteration of the receptor expression, signaling and endocytic traffic. Oncogene 30, 4963–4976 (2011). https://doi.org/10.1038/onc.2011.203
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2011.203
Keywords
This article is cited by
-
MALAT1-miR-124-RBG2 axis is involved in growth and invasion of HR-HPV-positive cervical cancer cells
Tumor Biology (2016)
-
Expression of HPV16 E5 down-modulates the TGFbeta signaling pathway
Molecular Cancer (2013)
-
Nip the HPV encoded evil in the cancer bud: HPV reshapes TRAILs and signaling landscapes
Cancer Cell International (2013)